Anvildiagnostics
1 known investors
Anvil Diagnostics develops MycoScan, a pan-fungal assay that detects, identifies, and quantifies fungal pathogens by measuring microbial cell-free DNA in patient plasma using digital PCR and a reconstruction algorithm, returning results in under three hours. The test targets invasive fungal infections in immunocompromised patients and is currently offered as a research use only product, drawing on technology from Rice University.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Anvildiagnostics do?
- Anvil Diagnostics develops MycoScan, a pan-fungal assay that detects, identifies, and quantifies fungal pathogens by measuring microbial cell-free DNA in patient plasma using digital PCR and a reconstruction algorithm, returning results in under three hours. The test targets invasive fungal infections in immunocompromised patients and is currently offered as a research use only product, drawing on technology from Rice University.
- Who are Anvildiagnostics's investors?
- Anvildiagnostics's investors include Launchpad Venture Group.